CINECA IRIS Institutional Research Information System

GONTERO, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.120
EU - Europa 12.008
AS - Asia 5.257
SA - Sud America 156
AF - Africa 91
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 14
Totale 32.707
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.952
IT - Italia 5.336
CN - Cina 2.266
IE - Irlanda 1.402
SG - Singapore 1.355
SE - Svezia 1.086
FR - Francia 928
KR - Corea 669
DE - Germania 615
FI - Finlandia 560
UA - Ucraina 505
AT - Austria 350
GB - Regno Unito 310
IN - India 220
DK - Danimarca 213
VN - Vietnam 198
PL - Polonia 176
CA - Canada 134
ID - Indonesia 103
JP - Giappone 102
BE - Belgio 95
ES - Italia 90
HK - Hong Kong 90
BR - Brasile 86
NL - Olanda 78
TR - Turchia 61
AU - Australia 53
IL - Israele 52
RU - Federazione Russa 49
CH - Svizzera 46
TW - Taiwan 32
IR - Iran 30
PT - Portogallo 29
MX - Messico 27
RO - Romania 27
SN - Senegal 24
GR - Grecia 20
UZ - Uzbekistan 20
PE - Perù 16
NG - Nigeria 15
TH - Thailandia 15
CL - Cile 14
AR - Argentina 13
BY - Bielorussia 13
EU - Europa 13
CO - Colombia 12
CZ - Repubblica Ceca 12
EE - Estonia 11
ZA - Sudafrica 10
BO - Bolivia 9
EG - Egitto 9
NO - Norvegia 9
MU - Mauritius 8
MY - Malesia 8
NZ - Nuova Zelanda 8
BG - Bulgaria 7
IQ - Iraq 7
EC - Ecuador 5
HR - Croazia 5
LT - Lituania 5
MA - Marocco 5
SA - Arabia Saudita 5
GI - Gibilterra 4
PH - Filippine 4
PK - Pakistan 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
HU - Ungheria 3
KE - Kenya 3
LC - Santa Lucia 3
LV - Lettonia 3
MK - Macedonia 3
QA - Qatar 3
RS - Serbia 3
SC - Seychelles 3
TZ - Tanzania 3
AL - Albania 2
BD - Bangladesh 2
CI - Costa d'Avorio 2
LU - Lussemburgo 2
MD - Moldavia 2
MZ - Mozambico 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
A1 - Anonimo 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CR - Costa Rica 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GF - Guiana Francese 1
GT - Guatemala 1
KG - Kirghizistan 1
KW - Kuwait 1
Totale 32.702
Salva come PNG Salva come JPEG
Città #
Chandler 2.411
Dublin 1.387
Beijing 1.375
Santa Clara 1.274
Singapore 1.061
Houston 889
Ann Arbor 732
Torino 612
Villeurbanne 529
Ashburn 488
Princeton 453
Nyköping 445
Medford 437
Wilmington 433
Fairfield 423
Columbus 395
Jacksonville 376
Vienna 342
Dearborn 323
Milan 279
Rome 244
Turin 221
Woodbridge 218
Seattle 214
Cambridge 168
Boston 146
Warsaw 137
Guangzhou 127
Redwood City 118
Dong Ket 117
Pisa 113
Hangzhou 99
Jakarta 97
Fremont 93
Helsinki 83
Norwalk 82
Pune 75
Boardman 73
Naples 73
New York 69
Brussels 62
Munich 61
Hebei 53
Washington 51
Florence 48
Toronto 48
Mountain View 47
Hefei 45
Verona 45
Shanghai 44
Palermo 41
San Diego 38
Hong Kong 37
Bologna 36
Nanjing 36
Napoli 35
Chengdu 34
Falls Church 32
Seoul 32
Chicago 31
Los Angeles 30
Paris 30
Bari 27
Tokyo 25
Genoa 23
Kunming 23
Ottawa 23
Tel Aviv 23
Zhengzhou 23
Catania 22
Genova 22
Lappeenranta 22
Padova 22
Dallas 21
Jinan 21
Phoenix 21
Silver Spring 21
São Paulo 21
Berlin 19
Central District 19
Chennai 19
London 18
Shenyang 18
Taipei 18
Lachine 17
San Mateo 17
Xian 17
Istanbul 16
Nanchang 16
Duncan 15
Frankfurt am Main 15
Sydney 15
Wuhan 15
Guiyang 14
Wayne 14
Brescia 13
Changsha 13
Lima 13
Mumbai 13
Redmond 13
Totale 18.854
Salva come PNG Salva come JPEG
Nome #
Somministrazione intravescicale di Mitomicina C in ipertermia nei carcinomi vescicali superficiali a rischio intermedio 3.664
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 491
Urological consequences following renal transplantation: a review of the literature 384
Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I–II study 382
A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"? 346
Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients 341
New insights on occupational exposure and bladder cancer risk: a pooled analysis of two Italian case–control studies 334
microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes 325
Does Sex Reassignment Surgery Induce Cerebral Modifications in MTF Transsexuals? 317
Pharmacokinetic study to optimize the intravesical administration of gemcitabine 291
MMP23B expression and protein levels in blood and urine are associated with bladder cancer 286
H2AX phosphorylation level in peripheral blood mononuclear cells as an event-free survival predictor for bladder cancer 270
Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy 260
Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma. 258
Urine microRNA profiling in bladder cancer by next-generation sequencing 240
The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury 235
Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins 204
DKK-1 in prostate cancer diagnosis and follow up 203
Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up 191
Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison. 183
Targeting Taxanes to Castration-Resistant Prostate Cancer Cells by Nanobubbles and Extracorporeal Shock Waves 176
Can DW-MRI, with its ADC values, be a reliable predictor of biopsy outcome in patients with suspected prostate cancer? 174
A Comparative Study Between 2 Different Grafts Used as Patches After Plaque Incision and Inflatable Penile Prosthesis Implantation for End-Stage Peyronie's Disease 174
Miliary pulmonary infection after BCG intravesical instillation: a rare, misdiagnosed and mistreated complication 168
Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation 164
Sexual function after surgical treatment for penile cancer: Which organ-sparing approach gives the best results? 163
Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer 159
The prognostic value of basal DNA damage level in peripheral blood lymphocytes of patients affected by bladder cancer 156
Critical issues in current comparative and cost analyses between retropubic and robotic radical prostatectomy 155
Pros-IT CNR: an Italian prostate cancer monitoring project 154
A prospective multicentric international study on the surgical outcomes and patients' satisfaction rates of the 'sliding' technique for end-stage Peyronie's disease with severe shortening of the penis and erectile dysfunction 153
A Pharmacokinetics Study to Optimize Intravesical Administration of Gemcitabine 146
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 142
A Single-center Analysis on the Learning Curve of Male-to-Female Penoscrotal Vaginoplasty by Multiple Surgical Measures 140
Increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer 138
Self-Expandable Covered Metallic Stent (UVENTA) to Treat a Ureteral Stricture After Renal Transplant: A Case Report 138
Proposal of an improved prognostic classification for pT3 renal cell carcinoma 137
Prostatectomy restores the maturation competence of blood dendritic cell precursors and reverses the abnormal expansion of regulatory T lymphocytes. 137
Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: A Comparative Study 134
Shortened telomere length and survival in bladder cancer patients 128
Adrenal ganglioneuroma with multifocal retroperitoneal extension: a challenging diagnosis. 127
Detection of urinary prostate specific antigen by a lateral flow biosensor predicting repeat prostate biopsy outcome 123
SINGLE NUCLEOTIDE POLYMORPHISMS (SNP) AND HAPLOTYPES IN PSA PROMOTER: A NEW PROMISING PROSTATE CANCER SUSCEPTIBILITY AND PROGNOSIS PREDICTOR TOOL 118
Galenic containing green tea polyphenols, lycopene and selenium: evaluation of chemopreventive activity in prostat cancer 117
Surgical management of hypogonadic patients with hypotrophic testicles and small penis: A novel, combined technique with an infrapubic approach 116
Does kidney transplantation onto the external iliac artery affect the haemodynamic parameters of the cavernosal arteries? 113
Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI) 113
Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo 112
Pretreatment tables predicting pathologic stage of locally advanced prostate cancer. 111
Shorter Leukocyte Telomere Length Is Independently Associated with Poor Survival in Patients with Bladder Cancer 110
Implant of ATOMS® system for the treatment of postoperative male stress urinary incontinence: results of a single centre 108
Recipient pre-existing chronic hypotension is associated with delayed graft function and inferior graft survival in kidney transplantation from elderly donors 107
A prospective randomized trial about music listening to decrease discomfort during SWL. 106
Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection 106
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome. 106
Small non-coding RNA profiling in plasma extracellular vesicles of bladder cancer patients by next-generation sequencing: Expression levels of miR-126-3p and piR-5936 increase with higher histologic grades 106
Tubulocystic renal cell carcinoma disguised as a renal cyst 105
Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy. 105
Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results 104
A pilot phase-II prospective study to test the 'efficacy' and tolerability of a penile-extender device in the treatment of 'short penis' 103
Costs in Surgical Techniques for Radical Prostatectomy: A Review of the Current State. 102
PHARMACOKINETICS, PHARMACOLOGICAL STABILITY, SAFETY AND ACTIVITY OF MMC ADMINISTERED WITH A NEW HYPERTHERMIA DEVICE (UNITHERMIA) 101
[Female incontinence surgery: state of the art] 101
Androgen deprivation modulates gene expression profile along prostate cancer progression 101
Circadian antidiuretic hormone variation in elderly men complaining of persistent nocturia after urinary flow obstruction removal. 100
A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al. 100
Comparsa in due fratelli di duplice neoplasia primitiva: carcinoma renale destro ed adenocarcinoma gastrico. 100
[Adverse events after intravesical therapy: are we always ready to recognize and prevent them?] 99
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer 99
SHORTENED TELOMERE LENGTH AND SURVIVAL IN BLADDER CANCER PATIENTS 99
Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder. 98
Effect of finasteride on the sensitivity of PSA to detect prostate cancer in rebiopsy series. 98
A pharmacokinetics study to optimize intravesical administration of gemcitabine 97
TREATMENT OF PROSTATE CANCER AND SEXUAL REHABILITATION WHEN A NERVE-SPARING PROCEDURE IS NOT FEASIBLE: PLACEMENT OF THE RESERVOIR FOR A THREE-COMPONENT PENILE IMPLANT DURING ROBOTIC EXTRA-APONEUROTIC RADICAL PROSTATECTOMY 97
Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional database 97
L’associazione tra tumore della vescica e esposizioni professionali: analisi pooled di due studi casocontrollo italiani. 96
Polymorphisms in DNA repair genes, chemotherapy and survival in bladder cancer 93
Renal artery aneurysm treated with laparoscopic nephrectomy, ex vivo repair and autotransplantation. 92
Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase 92
Circulating microRNAs combined with PSA for accurate and non-invasive prostate cancer detection 92
The importance of psychosexual counselling in the re-establishment of organic and erotic functions after penile prosthesis implantation 92
Influence of previous pelvic radiation therapy in the outcome of radical cystectomy. 91
Re: A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. M. Savoie, S. S. Kim and M. S. Soloway. J Urol, 169: 1462-1464, 2003. 89
Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer. 89
Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study 89
An international field study of the EORTC QLQ-PR25: a Questionnaire for assessing the health-related quality of life of patients with prostate cancer 88
Treatment of multiple synchronous misdiagnosed renal cell cancers in a young patient affected by a "de novo" Von Hippel-Lindau syndrome 88
Penile length is normal in most men seeking penile lengthening procedures. 87
Retrograde Intrarenal Surgery is superior to SWL in the treatment of renal stones up to 20 mm 86
Pharmacokinetics, Pharmacological Stability, Safety and Efficacy of MMC Administered with a New Hyperthermia Device 86
68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy 86
Is there an optimal time for intracavernous prostaglandin E1 rehabilitation following nonnerve sparing radical prostatectomy? Results from a hemodynamic prospective study. 86
Cell-cycle Progression-Score Might Improve the Current Risk Assessment in Newly Diagnosed Prostate Cancer Patients 85
Comment On: Applying Extender Devices in Patients with Penile Dysmorphophobia: Assessment of Tolerability, Efficacy, and Impact on Erectile Function 85
Active surveillance for small renal tumors: Have clinical concerns been addressed so far? 85
Radiofrequency Ablation for Renal Cancer in Von Hippel-Lindau Syndrome Patients: A Prospective Cohort Analysis 85
Prognostic factors of 'high-grade' Ta bladder cancers according to the WHO 2004 classification: are these equivalent to 'high-risk' non-muscle-invasive bladder cancer? 85
Penile fracture repair: assessment of early results and complications using color Doppler ultrasound. 84
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis 84
BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder. 83
Totale 18.144
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.938
article - articoli 0
book - libri 0
conference - conferenze 10.862
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.667 0 0 0 0 0 808 403 231 355 291 306 273
2020/20213.338 264 256 259 194 352 226 279 182 324 310 263 429
2021/20224.148 131 188 185 323 179 136 198 273 127 279 1.154 975
2022/20237.077 760 873 157 690 594 1.632 544 424 675 174 333 221
2023/20243.151 373 505 203 179 156 384 165 142 37 212 264 531
2024/20254.354 166 566 293 728 1.922 679 0 0 0 0 0 0
Totale 33.966